TEL AVIV – An Israeli hospital will begin testing COVID-19 patients with medicinal cannabis, which is known to have anti-viral properties, as part of a new experimental treatment. Researchers are investigating cannabidiol, the non-psychoactive component of cannabis also known as CBD, can slow down the spread of the virus and stop moderate patients from turning critical. Dozens of COVID-19 patients in moderate condition at Ichilov Medical Center in Tel Aviv are expected to be treated. Barak Cohen, a senior anesthesiologist who is in charge of managing the hospital’s coronavirus response, stressed the treatment would alleviate symptoms by using “a component...